{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 1366"}, "official-title": {"#tail": "\n\t", "#text": "To direct the Commissioner of Food and Drugs to modify\n\t\t  the approval of any drug containing controlled-release oxycodone hydrochloride\n\t\t  to limit such approval to use for the relief of severe-only instead of\n\t\t  moderate-to-severe pain, and for other purposes."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130321", "#text": "March 21, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and\n\t\t\t Commerce"}, "sponsor": {"#tail": " (for\n\t\t\t himself, ", "#text": "Mr. Lynch", "@name-id": "L000562"}, "cosponsor": [{"#tail": ",\n\t\t\t ", "#text": "Mr. Fitzpatrick", "@name-id": "F000451"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Rogers of Kentucky", "@name-id": "R000395"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Rahall", "@name-id": "R000011"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Keating", "@name-id": "K000375"}, {"#tail": ", and\n\t\t\t ", "#text": "Mr. Wolf", "@name-id": "W000672"}, {"#tail": ") introduced the\n\t\t\t following bill; which was referred to the ", "#text": "Ms. Slaughter", "@name-id": "S000480"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H94D0256CED8F4A31BF7AA24DE16D517D", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Stop Oxy Abuse Act of\n\t\t\t 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "HCB679FDCD43B4F519BE683E881672C94"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Limiting approval\n\t\t\t of drugs containing controlled-release oxycodone hydrochloride to use for\n\t\t\t relief of severe-only pain"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall take such actions as may be necessary\u2014", "@entity-type": "federal-body", "#text": "Commissioner of Food and\n\t\t\t Drugs", "@entity-id": "7524"}, "#text": "Not later than 90\n\t\t\t days after the date of the enactment of this Act, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In\n\t\t\t general"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "to modify the\n\t\t\t approval of any drug containing controlled-release oxycodone hydrochloride\n\t\t\t under ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n\t\t\t to limit such approval to use for the relief of severe-only instead of\n\t\t\t moderate-to-severe pain; and", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 505 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "@parsable-cite": "usc/21/355", "#text": "21 U.S.C. 355", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "HF494DF34D9A04D39B91F97F54830096C", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "to limit any\n\t\t\t subsequent approval of a drug containing controlled-release oxycodone\n\t\t\t hydrochloride under such section to use for the relief of severe-only\n\t\t\t pain."}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H84A3522E7CE443C7A3A9C68D4106F0C1", "#text": "\n          "}], "#text": "\n        ", "@id": "H800CE6B9AFC94B4FA05919CD2892D903"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall apply to drugs introduced or\n\t\t\t delivered for introduction into interstate commerce on or after the date that\n\t\t\t is 180 days after the date of the enactment of this Act.", "@entity-type": "act", "#text": "subsection (a)(1)", "@value": "Stop Oxy Abuse Act of 2013/s:2/ss:a/p:1", "@proposed": "true"}, "#text": "Any\n\t\t\t modification required by "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Applicability"}, "#text": "\n        ", "@id": "H208310069E5B4E30850B9B40E8DE143F"}], "#text": "\n      ", "@id": "H7ED4A5F555634C4C843B123EC4414191"}], "#text": "\n\t\t", "@id": "H41A178E7E31B43A7BB1D76518C263D97"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-03-21"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 1366 IH: Stop Oxy Abuse Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}